Correlation Between Tarsus Pharmaceuticals and Mink Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Mink Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Mink Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Mink Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tarsus and Mink is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Mink Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Mink Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.15 times more return on investment than Mink Therapeutics. However, Tarsus Pharmaceuticals is 1.15 times more volatile than Mink Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 3,263 in Tarsus Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 1,982 from holding Tarsus Pharmaceuticals or generate 60.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Mink Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Mink Therapeutics |
Tarsus Pharmaceuticals and Mink Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Mink Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.The idea behind Tarsus Pharmaceuticals and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |